Has Kurt Oelke, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,818,046 in general payments to Kurt Oelke, MD across 1,735 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kurt Oelke, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kurt Oelke, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kurt Oelke, MD

Rheumatology · Glendale, WINPI 1962433136

Payments from drug & device makers

$1,818,046in general payments, 2019–2025

Across 1,735 payments — averaging $1047.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$386K
E.r. Squibb & Sons, L.L.C.$349K
GSK$229K
Amgen$175K
Eli Lilly$158K
Johnson & Johnson$93K
plus $428K from 38 others

$9,115in research payments, 2019–2025

Across 6 payments — averaging $1519.10 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Pfizer$6K
Novartis$3K
Eli Lilly$433

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	378	$385,505
E.r. Squibb & Sons, L.L.C.	75	$348,917
GSK	104	$229,353
Amgen(2 entities)	254	$174,634
Eli Lilly	46	$158,450
Johnson & Johnson(2 entities)	130	$93,422
UCB, Inc.	168	$91,585
UCB SA	3	$81,495
AstraZeneca(2 entities)	116	$75,669
Novartis	87	$60,726
Pfizer	87	$45,070
Lilly USA, LLC	122	$35,801
Janssen Research & Development, LLC	10	$11,093
Fresenius Kabi USA, LLC	13	$5,787
Sanofi	13	$5,379
Janssen Scientific Affairs, LLC	18	$5,347
Sobi, Inc	13	$4,254
Regeneron Healthcare Solutions, Inc.	12	$3,506
ANI Pharmaceuticals, Inc.	8	$196
Aurinia Pharma U.S., Inc.	4	$177
Organon	9	$176
Actelion Pharmaceuticals US, Inc.	4	$173
Genentech USA, Inc.	6	$148
Boehringer Ingelheim	7	$142
Sandoz	5	$126
Ferring Pharmaceuticals Inc.	5	$111
Celltrion USA Inc.	4	$99
Sanofi-aventis U.S. LLC	4	$90
Genentech, Inc.	2	$82
Hospira, Inc.	4	$81
Takeda Pharmaceuticals U.S.A., Inc.	3	$74
Ultragenyx Pharmaceutical Inc.	3	$61
Kyowa Kirin, Inc.	3	$59
Gilead	2	$55
Collegium Pharmaceutical, Inc.	3	$44
Merck	2	$28
Octapharma USA, Inc.	1	$25
Kiniksa Pharmaceuticals International, PLC	1	$18
Bristol Myers Squibb	1	$17
Mallinckrodt Hospital Products Inc.	1	$16
Kiniksa Pharmaceuticals, Ltd.	1	$15
Radius Health, Inc.	1	$14
Tonix Medicines, Inc.	1	$14
Bioventus LLC	1	$11

How this compares

$1,818,046 in reported general payments places this provider in the 95th percentile of 120 rheumatology providers in Wisconsin.

See all rheumatology providers in Wisconsin →

Medicare billing

Part B allowed, 2024

$1,614,534

Medicare patients

277

Services billed

100,303

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other rheumatology in Glendale

John AlbertGlendale$369K
Arnold LimGlendale$8K
Jonathan KushiGlendale$5K
Katherine FinnGlendale$2K
Farrukh PashaGlendale$1K
Steven BergquistGlendale$722
Juliana ShahGlendale$513
Daniel MaloneBeaver Dam$505K
Ekaterina SoforoSheboygan$464K
Fardina MalikMadison$446K

See the full list for Wisconsin →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →